France fines Sanofi for bad-mouthing generics

05/14/2013 | Bloomberg

France's antitrust regulator fined drugmaker Sanofi $52.8 million for casting doubt with doctors and pharmacists about the safety and efficacy of generic versions of the blood-thinner Plavix. Regulators say Sanofi urged doctors to require prescriptions for the branded drug be dispensed as written and tried to persuade pharmacists to use Sanofi's generic version instead of others.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
AIMD Product Expert
BSI
Nationwide, SL_Nationwide
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Finance Manager - ENT
Medtronic
Jacksonville, FL
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC